DELFI Diagnostics, Inc.
DELFI is seeking an experienced contract Clinical Data Manager to provide supplemental capacity for the DELFI-L201 IVD Clinical Validation study. The role involves ongoing data cleaning, query management, and database lock preparation within the study EDC and data collection systems. The position also includes developing derived variable specifications and supporting table, figure, and listing requirements.
Headquarters
Palo Alto, California, United States
Company Size
51-200 employees
Founded
2019
DELFI Diagnostics is a biotech company focused on saving lives through early cancer detection with blood-based tests. Their platform analyzes cell-free DNA fragmentation patterns using genome-wide sequencing and machine learning to noninvasively detect and localize multiple cancer types from a routine blood draw. DELFI develops tests for screening, diagnosis, and disease monitoring and advances validation through clinical collaborations and trials. The company’s mission is to deliver sensitive, scalable liquid‑biopsy solutions that enable earlier intervention and better outcomes for patients.
DELFI Diagnostics Appoints Cindy Soriano as Chief Financial Officer and Announces Participation in 44th Annual J.P. Morgan Healthcare Conference
Jan 8, 2026
DELFI Diagnostics to Present Early Detection and Advanced Cancer Monitoring Technology Updates at AACR Annual Meeting
Apr 25, 2025
DELFI Diagnostics CTO Dr. Amoolya Singh Recognized Among 2025 Most Influential Women in Bay Area Business
May 12, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for DELFI Diagnostics, Inc..
20% above the average for this role
Delfi Diagnostics Announces $225 Million in Series B
Jul 21, 2022